BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8876194)

  • 1. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.
    Sheng S; Carey J; Seftor EA; Dias L; Hendrix MJ; Sager R
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11669-74. PubMed ID: 8876194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin. A tumor suppressing serpin.
    Sager R; Sheng S; Pemberton P; Hendrix MJ
    Adv Exp Med Biol; 1997; 425():77-88. PubMed ID: 9433491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, purification, and characterization of recombinant maspin proteins.
    Sheng S; Pemberton PA; Sager R
    J Biol Chem; 1994 Dec; 269(49):30988-93. PubMed ID: 7983035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma linolenic acid regulates expression of maspin and the motility of cancer cells.
    Jiang WG; Hiscox S; Horrobin DF; Bryce RP; Mansel RE
    Biochem Biophys Res Commun; 1997 Aug; 237(3):639-44. PubMed ID: 9299418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.
    Zhang M; Sheng S; Maass N; Sager R
    Mol Med; 1997 Jan; 3(1):49-59. PubMed ID: 9132279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin inhibits cell migration in the absence of protease inhibitory activity.
    Bass R; Fernández AM; Ellis V
    J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin: a tumor suppressing serpin.
    Sager R; Sheng S; Pemberton P; Hendrix MJ
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():51-64. PubMed ID: 8814994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.
    Maass N; Hojo T; Zhang M; Sager R; Jonat W; Nagasaki K
    Acta Oncol; 2000; 39(8):931-4. PubMed ID: 11206999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
    Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells.
    Li JJ; Colburn NH; Oberley LW
    Carcinogenesis; 1998 May; 19(5):833-9. PubMed ID: 9635871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. maspin suppresses the invasive phenotype of human breast carcinoma.
    Seftor RE; Seftor EA; Sheng S; Pemberton PA; Sager R; Hendrix MJ
    Cancer Res; 1998 Dec; 58(24):5681-5. PubMed ID: 9865722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
    Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
    Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
    Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
    Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.
    Shi HY; Zhang W; Liang R; Abraham S; Kittrell FS; Medina D; Zhang M
    Cancer Res; 2001 Sep; 61(18):6945-51. PubMed ID: 11559574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin is physically associated with [beta]1 integrin regulating cell adhesion in mammary epithelial cells.
    Cella N; Contreras A; Latha K; Rosen JM; Zhang M
    FASEB J; 2006 Jul; 20(9):1510-2. PubMed ID: 16720730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership.
    Bailey CM; Khalkhali-Ellis Z; Kondo S; Margaryan NV; Seftor RE; Wheaton WW; Amir S; Pins MR; Schutte BC; Hendrix MJ
    J Biol Chem; 2005 Oct; 280(40):34210-7. PubMed ID: 16049006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.